P138: Evaluating the impact of gnomAD v4 on genetic prevalence estimates*
Genetics in Medicine Open · 2024 · 2 · 101035
DOI: 10.1016/j.gimo.2024.101035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics in Medicine Open, 2024. Verfasst von Samantha Baxter und 10 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Baxter, S., Singer-Berk, M., Russell, K., Amin, M., Glaze, C., Grant, R., Lee, J., Watts, N., Wilson, M., Rehm, H., & O'Donnell-Luria, A. (2024). P138: Evaluating the impact of gnomAD v4 on genetic prevalence estimates*. Genetics in Medicine Open, 2, 101035. https://doi.org/10.1016/j.gimo.2024.101035
Vancouver
Baxter S, Singer-Berk M, Russell K, Amin M, Glaze C, Grant R, et al. P138: Evaluating the impact of gnomAD v4 on genetic prevalence estimates*. Genetics in Medicine Open. 2024;2:101035. doi:10.1016/j.gimo.2024.101035
BibTeX
@article{Baxter2024,
author = {Baxter, Samantha and Singer-Berk, Moriel and Russell, Kathryn and Amin, Mutaz and Glaze, Carmen and Grant, Riley and Lee, Josephine and Watts, Nick and Wilson, Michael and Rehm, Heidi and O'Donnell-Luria, Anne},
title = {P138: Evaluating the impact of gnomAD v4 on genetic prevalence estimates*},
journal = {Genetics in Medicine Open},
year = {2024},
volume = {2},
pages = {101035},
doi = {10.1016/j.gimo.2024.101035}
}
EUVIMED